Close

T.J. Martell Foundation Deposits $1.2 Million in Preston Labs

Posted in News on April 19, 2004
The T.J. Martell Foundation for Leukemia, Cancer, and AIDS Research presented a check for $1.2 million to the Frances Williams Preston Labs at Vanderbilt-Ingram Cancer Center during its January board meeting. To date, the Martell Foundation has raised $13 million to support the Preston Labs. In turn, these contributions have been leveraged to obtain additional funding -- totaling more than $96 million -- from public and private sources to further advance the ongoing effort to alleviate suffering from cancer.

Pictured at the new Vanderbilt Children's Hospital are Martell Foundation Board member Gary Chapman, Vanderbilt-Ingram Cancer Center Director Dr. Hal Moses, Martell Foundation Board Chairman Bill Hearn of EMI Christian Music Group, Martell Foundation Executive Director Roxanne Johnson, Martell Foundation Board member Ronnie Dunn of Brooks & Dunn and Foundation Board member Paul Corbin of BMI. Photo by Peyton Hoge

Primarily supported by the music industry, the Martell Foundation has maintained its high level of support despite the recent slump in music sales and the continuing impact of corporate mergers, demonstrating the leadership, commitment and giving spirit of country music and the ongoing work of the Martell Foundation's board and staff.

The T.J. Martell Foundation was founded in 1975 by music industry executive Tony Martell and his colleagues after leukemia claimed the life of Tony's son, T.J. The Foundation has raised more than $180 million to fund research for the innovative cures and treatments of leukemia, cancer and AIDS at nine research facilities throughout the United States. Locally, the T.J. Martell Foundation supports the Frances Williams Preston Laboratories at Vanderbilt-Ingram Cancer Center, named for BMI President & CEO Preston.